Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, A.
Right arrow Articles by Korman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, A.
Right arrow Articles by Korman, N.
American Journal of Health-System Pharmacy, Vol 59, Issue 21, 2070-2077
Copyright © 2002 by American Society of Health-System Pharmacists


Articles

Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center

AJ Lee, MS Boro, KK Knapp, JL Meier, and NE Korman


Pharmacist recommendations and their clinical and economic outcomes in a Veterans Affairs (VA) medical center were studied. The first 600 pharmacist recommendations that met study criteria were evaluated for type and frequency, rate of acceptance by physicians, potential benefit or harm, and economic consequences. The study site included inpatient and outpatient settings and a skilled-nursing facility. The most frequent types of pharmacist recommendations involved adjusting the dosage or frequency of administration and discontinuing a drug that was not indicated for the patient's medical problem. The rate of acceptance of the recommendations was 92%. The recommendations led to improved clinical outcomes in over 30% of cases in each setting and no change in over 40% of cases in each setting. Evaluators determined that patient harm was avoided by the recommendations in 90% of cases; patient harm was caused in less than 1% of cases. The overall mean cost avoidance per recommendation was $700, and the mean total cost avoidance for all 600 recommendations was $420,155. Pharmacist recommendations improved clinical outcomes and saved money at a VA medical center.
 



This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
T. M. Meidl, T. W. Woller, A. M. Iglar, and D. G. Brierton
Implementation of pharmacy services in a telemedicine intensive care unit
Am. J. Health Syst. Pharm., August 1, 2008; 65(15): 1464 - 1469.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
T. De Rijdt, L. Willems, and S. Simoens
Economic effects of clinical pharmacy interventions: A literature review
Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1161 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
J. N. Brown, C. L. Barnes, B. Beasley, R. Cisneros, M. Pound, and C. Herring
Effect of pharmacists on medication errors in an emergency department
Am. J. Health Syst. Pharm., February 15, 2008; 65(4): 330 - 333.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
M. Heelon, D. Skiest, G. Tereso, L. Meade, J. Weeks, P. Pekow, and M. B. Rothberg
Effect of a clinical pharmacist's interventions on duration of antiretroviral-related errors in hospitalized patients
Am. J. Health Syst. Pharm., October 1, 2007; 64(19): 2064 - 2068.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
B. I. Fox, B. G. Felkey, B. A. Berger, K. P. Krueger, and R. K. Rainer Jr.
Use of personal digital assistants for documentation of pharmacists' interventions: A literature review
Am. J. Health Syst. Pharm., July 15, 2007; 64(14): 1516 - 1525.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
P. Lada and G. Delgado Jr.
Documentation of pharmacists' interventions in an emergency department and associated cost avoidance
Am. J. Health Syst. Pharm., January 1, 2007; 64(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
W. N. Kelly and T. D. Rucker
Compelling features of a safe medication-use system.
Am. J. Health Syst. Pharm., August 1, 2006; 63(15): 1461 - 1468.
[Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
D. J. Weschules, T. Maxwell, J. Reifsnyder, and C. H. Knowlton
Are newer, more expensive pharmacotherapy options associated with superior symptom control compared to less costly agents used in a collaborative practice setting?
American Journal of Hospice and Palliative Medicine, March 1, 2006; 23(2): 135 - 149.
[Abstract] [PDF]


Home page
Am J Health Syst PharmHome page
J. M. Ling, L. A. Mike, J. Rubin, P. Abraham, A. Howe, J. Patka, and D. Vigliotti
Documentation of pharmacist interventions in the emergency department
Am. J. Health Syst. Pharm., September 1, 2005; 62(17): 1793 - 1797.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
K. K. Knapp, M. P. Okamoto, and B. L. Black
ASHP survey of ambulatory care pharmacy practice in health systems--2004
Am. J. Health Syst. Pharm., February 1, 2005; 62(3): 274 - 284.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Health-System Pharmacists.